Grape King Bio (1707) Stock Overview
Produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food in Taiwan, China, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
1707 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Grape King Bio Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$130.00 |
| 52 Week High | NT$158.00 |
| 52 Week Low | NT$119.50 |
| Beta | 0.42 |
| 1 Month Change | 6.56% |
| 3 Month Change | 0.78% |
| 1 Year Change | -14.75% |
| 3 Year Change | -1.52% |
| 5 Year Change | -22.39% |
| Change since IPO | 105.54% |
Recent News & Updates
Recent updates
Grape King Bio's (TWSE:1707) Dividend Will Be NT$6.90
Jun 17
Grape King Bio (TWSE:1707) Will Pay A Dividend Of NT$6.90
Jun 02Grape King Bio (TPE:1707) Knows How To Allocate Capital
Apr 06Here's Why Grape King Bio (TPE:1707) Can Manage Its Debt Responsibly
Mar 22Grape King Bio's (TPE:1707) Anemic Earnings Might Be Worse Than You Think
Mar 06How Much Did Grape King Bio's(TPE:1707) Shareholders Earn From Share Price Movements Over The Last Year?
Feb 27Grape King Bio (TPE:1707) Seems To Use Debt Quite Sensibly
Nov 20Shareholder Returns
| 1707 | TW Personal Products | TW Market | |
|---|---|---|---|
| 7D | 4.8% | 0.3% | -0.06% |
| 1Y | -14.8% | -14.8% | 21.3% |
Return vs Industry: 1707 matched the TW Personal Products industry which returned -14.8% over the past year.
Return vs Market: 1707 underperformed the TW Market which returned 21.3% over the past year.
Price Volatility
| 1707 volatility | |
|---|---|
| 1707 Average Weekly Movement | 1.7% |
| Personal Products Industry Average Movement | 4.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in TW Market | 8.6% |
| 10% least volatile stocks in TW Market | 2.0% |
Stable Share Price: 1707 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 1707's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1969 | n/a | n/a | www.grapeking.com.tw |
Grape King Bio Ltd, together with its subsidiaries, produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food in Taiwan, China, and internationally. It operates through Multi-Level Marketing; Distributors; Original Design Manufacturer/Original Equipment Manufacturer; and Sales Channel segments. The company offers Chinese herbal medicines, probiotics, energy drinks, and health food supplements for gastrointestinal health, immunity regulation, female beauty, and health care.
Grape King Bio Ltd Fundamentals Summary
| 1707 fundamental statistics | |
|---|---|
| Market cap | NT$19.26b |
| Earnings (TTM) | NT$1.34b |
| Revenue (TTM) | NT$10.88b |
Is 1707 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1707 income statement (TTM) | |
|---|---|
| Revenue | NT$10.88b |
| Cost of Revenue | NT$2.53b |
| Gross Profit | NT$8.35b |
| Other Expenses | NT$7.01b |
| Earnings | NT$1.34b |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 9.05 |
| Gross Margin | 76.77% |
| Net Profit Margin | 12.32% |
| Debt/Equity Ratio | 0% |
How did 1707 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/14 22:11 |
| End of Day Share Price | 2025/11/14 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Grape King Bio Ltd is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hongyan Lin | CGS International |
| Nicholas Lai | HSBC |
| Hsiu Chi Lin | Masterlink Securities Corp. |